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Abstract
Genetic characterization of wild-type measles viruses (MVs) is an important component of laboratory surveillance of measles. In this
study, a phylogenetic analysis was performed of the nucleoprotein gene sequences of 228 MVs isolated in the Russian Federation
between 2003 and 2007. Five genotypes, D4, D5, D6, D8, and H1, were detected. From 1999 through the ﬁrst 6 months of 2003, the
most prevalent genotype in the European part of Russia was D4. All genotype D4-type viruses were closely related to each other (with
overall sequence diversity of £0.9%), suggesting the presence of a single endemic MV strain. After 2003, viruses with closely related
sequences within genotype D6 (£0.9% sequence diversity) were prevalent. During this time, there was a low level of indigenous trans-
mission of genotype D6, and genotype D6 viruses were imported from neighbouring countries, which led to the identiﬁcation of two
lineages of genotype D6, i.e. D6a and D6b. Lineage D6a was closely related to viruses isolated in Turkey, Kazakhstan, and Uzbekistan,
whereas lineage D6b was linked to a large outbreak in Ukraine in 2005–2006. Genotypes H1, D5 and D8 were associated with sporadic
cases and clusters of transmission linked to importations. Enhanced vaccination interrupted the transmission of the previous endemic
lineage D4 in 2003 and of lineage D6a in 2005, although an accumulation of susceptible individuals in the population allowed for pro-
longed circulation of lineage D6b. These data on MV genotype distribution, in conjunction with the epidemiological data for measles,
show considerable progress in measles control and suggest that regional elimination is possible.
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Introduction
Globally, measles morbidity and mortality have been dramati-
cally reduced since the implementation of enhanced vaccina-
tion strategies [1,2], and interruption of indigenous
transmission of measles virus (MV) (family, Paramyxoviridae;
genus, Morbillivirus) has been reported from several countries
[3]. Nonetheless, measles remains a leading cause of child-
hood mortality, with approximately 345 000 deaths in 2005,
most of which occurred in developing countries [4,5]. Fur-
thermore, large outbreaks continue to occur in countries
with high vaccination coverage after importation of the virus
from endemic regions [6,7].
Measles elimination in the European Region (EURO) of the
WHO has been targeted for 2010. During the period
between 2003 and 2006, many of the measles outbreaks in
the EURO were observed in the newly independent states
(Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyz-
stan, Moldova, Russian Federation, Tajikistan, Turkmenistan,
Ukraine, and Uzbekistan). Thus, the progress in measles
control in this region in general, and in the Russian Federa-
tion in particular, is critical for the success of the measles
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elimination programme in the EURO [8]. The Russian Measles
Elimination Programme, initiated in 2002, shares the regional
goal of measles elimination by 2010. Routine measles vaccina-
tion was introduced in Russia in 1967, and a two-dose strat-
egy was introduced in 1987, with children vaccinated at the
age of 12 months and again at the age of 6 years.
Despite overall vaccination coverage of more than 95%,
both with the ﬁrst and with the second dose, many outbreaks
and sporadic cases were reported throughout Russia during
the period 2003–2006. Analysis of the incidence data for 2002
and 2003 showed that more than 40% of measles patients
were between 18 and 35 years of age, and that most of them
had no history of vaccination. Therefore, supplementary
immunization campaigns targeting all individuals of this age
group were started in 2004. As a result, measles incidence
steadily decreased, and reached a historically low level in 2007
(Fig. 1).
Owing to a signiﬁcant decrease in measles incidence, case-
based notiﬁcation of outbreaks and sporadic cases was
implemented in 2002. Laboratory conﬁrmation of measles
cases increases the sensitivity of measles surveillance, and is
particularly important in countries that are in the elimination
phase [9]. Therefore, a laboratory network with one national
reference laboratory and ten subnational laboratories was
established in Russia in 2002. Since then, the percentage of
reported measles cases that were laboratory conﬁrmed has
continuously increased (Fig. 1), reaching more than 98% in
2007 (Fig. 1). Moreover, the number of suspected cases with
laboratory-tested sera considerably exceeded the number of
reported measles cases, which is indicative of the sensitivity
of the national surveillance system.
Genotyping of MV is a useful tool for measuring the
impact of measles vaccination, and has become an important
component of measles surveillance [10,11]. Genetic charac-
terization of wild-type MVs combined with standard epidemi-
ological methods helps to document chains of transmission
and to illustrate the progress towards elimination by differ-
entiating between indigenous and imported viruses [12–14].
In this study, the genetic characteristics of representative
wild-type MVs, identiﬁed in the Russian Federation between
2003 and 2007, were analysed, to illustrate the impact of the
enhanced vaccination programme and to determine the
sources of measles importation.
Materials and Methods
Clinical specimens and virus isolation
Heparinized blood, urine and nasopharyngeal samples were
collected from serologically conﬁrmed measles cases as sug-
gested by the WHO [9]. Measles-speciﬁc IgM antibodies in
serum were detected using a commercial enzyme immunoassay
(Enzygnost; Dade Behring, Eschborn, Germany).
MV isolates were obtained by co-cultivation of the cellular
fractions of different clinical specimens with B95a [15] or
Vero/hSLAM [16] cells. The cells were blind-passaged up to
three times after inoculation, and virus-positive cultures
were harvested when the cytopathic effect was maximal. A
summary of the MVs characterized in this study is presented
in Table 1.
RNA extraction and RT-PCR
RNA was extracted directly from clinical specimens or from
cell culture lysates using the QIAamp Viral RNA Mini Kit
(QiaGen, Hilden, Germany), according to the manufacturer’s
instructions. Partial nucleoprotein gene segments of MV
including the 450 terminal nucleotides were ampliﬁed by
RT-PCR using previously published primers and methods
[10,17,18]. PCR products were analysed by electrophoresis
through agarose gels, ethidium bromide staining, and UV
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FIG. 1. Measles morbidity, incidence and
laboratory conﬁrmation of suspected
measles cases in the Russian Federation
between 1998 and 2007. Reported cases
were clinically diagnosed and/or epide-
miologically linked and/or laboratory
conﬁrmed (G. N. Gabrichevsky Research
Institute, unpublished data).
CMI Shulga et al. Measles virus genotypes in Russia, 2003–2007 529
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 15, 528–537
TABLE 1. List of representative strains from the Russian Federation between 2003 and 2007
Name of straina Genotypea Dateb Source of virus Epidemiological statusc GenBank accession number
MVi/Astrakhan.RUS/12.03/1 D4 03/03 Isolate Outbreak, indigenous AY920716
MVi/Astrakhan.RUS/12.03/2 D4 03/03 Isolate Outbreak, indigenous AY920717
MVi/Moscow.RUS/13.03/2 D6a 03/03 Isolate No data AY920714
MVi/Moscow.RUS/15.03 D4 04/03 Isolate No data AY920715
MVi/Dagestan.RUS/20.03 D6a 05/03 Isolate Outbreak, indigenous AY920712
MVi/Moscow.RUS/25.03/2 D6a 06/03 Isolate No data EU925763
MVs/Saransk.RUS/26.03 D4 07/03 TS Sporadic, indigenous EU925764
MVi/Moscow.RUS/29.03/2 D4 07/03 Isolate No data AY920728
MVi/Novokuzneck.RUS/44.03/1 D6a 10/03 Isolate Outbreak, indigenous AY920727
MVs/Rostov-on-Don.RUS/44.03/1 D6a 11/03 Isolate Outbreak, indigenous NA
MVi/N.Osetia.RUS/51.03 D6a 12/03 Isolate Outbreak, indigenous AY920726
MVi/Moscow.RUS/3.04/1 D6a 01/04 Isolate No data EU109769
Mvs/Krasnoyarsk.RUS/03.04 D6a 01/04 U Outbreak, indigenous NA
MVs/Rostov-on-Don.RUS/4.04 D6a 01/04 U Outbreak, indigenous NA
MVi/Blagoveshchensk.RUS/14.04/1 H1 04/04 Isolate Outbreak, China AY920722
MVi/S-Petersburg.RUS/16.04/1 D6a 04/04 Isolate Outbreak, indigenous AY920720
MVs/S-Sahalinsk.RUS/18.04/1 D6a 05/04 TS Outbreak, indigenous NA
Mvs/Moscow.RUS/4.05 D6a 01/05 PBMC No data EU117222
Mvs/Novosibirsk.RUS/6.05 D6a 02/05 PBMC Outbreak, indigenous EU597260
Mvs/Irkutsk.RUS/09.05 D6a 03/05 TS Sporadic, indigenous EU597261
Mvs/Rostov-on-Don.Rus/11.05 D6a 03/05 U Outbreak, indigenous EU117223
Mvs/Rostov-on-Don.RUS/13.05/2 D6a 01/05 TS Outbreak, indigenous EU117225
Mvs/Ryazan.RUS/26.05 D6a# 06/05 TS Sporadic, indigenous EU117226
Mvs/NizhniyNovgorod.RUS/35.05 D6a 09/05 TS Sporadic, indigenous EU597262
Mvs/Vladimir.RUS/40.05 D6b 11/05 U Outbreak, indigenous EU117227
Mvs/Kursk.RUS/45.05 D6b 11/05 U Outbreak, indigenous NA
Mvs/Kursk.RUS/02.06/2 D6b# 02/06 TS Outbreak, indigenous EU117228
Mvs/Moscow.RUS/03.06 D6b 01/06 TS No data EU597263
Mvs/Moscow.RUS/04.06/7 D6b# 01/06 TS No data EU117231
Mvs/Orel.RUS/07.06 D6b 02/06 U Outbreak, indigenous NA
Mvs/Moscow.RUS/08.06 D6b# 02/06 TS Sporadic, Ukraine EU597246
Mvs/Tver.RUS/08.06 D6b 02/06 TS Outbreak, indigenous NA
Mvs/Moscow.RUS/11.06/4 D6b 03/06 TS No data EU117231
Mvs/Moscow.RUS/11.06/9 D6b 03/06 TS Sporadic, Ukraine NA
Mvs/Moscow.RUS/11.06/10 D6a 03/06 TS Sporadic, Uzbekistan NA
Mvs/Orenburg.RUS/12.06 D6a 03/06 TS Outbreak, Uzbekistan EU597259
Mvs/Moscow.RUS/12.06 H1 03/06 TS Sporadic, China EU597247
Mvi/Moscow.RUS/14.06/1 D6b 04/06 Isolate No data NA
MvsMoscow.RUS/14.06/3 D6b 04/06 TS Sporadic, Ukraine EU597248
Mvs/Tver.RUS/14.06 D6a 04/06 TS Sporadic, indigenous EU105466
Mvs/Perm.RUS/15.06/1 D6a 04/06 U Outbreak, indigenous NA
Mvs/Orenburg.RUS/16.06 D6a 04/06 TS Outbreak, Uzbekistan EU109771
Mvs/Moscow.RUS/19.06/4 D6b 05/06 TS Sporadic, Ukraine NA
Mvs/Moscow.RUS/20.06/1 D6b 05/06 TS Sporadic, Ukraine NA
Mvs/Bryansk.RUS/21.06 D6b 05/06 TS Sporadic, indigenous NA
Mvs/Saransk.RUS/21.06 D6b 05/06 TS Sporadic, indigenous NA
Mvs/Irkutsk.RUS/22.06 D6b 05/06 TS Sporadic, Ukraine NA
Mvs/Vladimir.RUS/22.06 D6b 06/06 TS Sporadic, indigenous NA
Mvs/Chita.RUS/23.06 H1 06/06 U Sporadic, unknown source EU105467
Mvs/Reutovo.RUS/23.06 D6b 06/06 U No data NA
Mvs/Balashyha.RUS/23.06 D6b 06/06 TS No data NA
Mvs/Korolev.RUS/25.06 D6b 06/06 U No data NA
Mvs/Buryatya.RUS/25.06 H1 06/06 U Outbreak, unknown source EU597249
Mvs/Irkutsk.RUS/26.06 H1 06/06 TS Sporadic, unknown source EU117232
Mvs/Chita.RUS/26.06 H1 06/06 TS Sporadic, unknown source EU109772
Mvs/Chelyabinsk.RUS/32.06 D6b 09/06 TS Sporadic, Ukraine NA
Mvs/Moscow.RUS/32.06 D6b 08/06 U Sporadic, Ukraine NA
Mvs/Ufa.RUS/38.06 D6b 09/06 U Sporadic, indigenous NA
Mvs/Chelyabinsk.RUS/48.06/1 D5 11/06 U Outbreak, Thailand EU597250
Mvs/Moscow/RUS/3.07/1 D5 01/07 TS Sporadic, unknown source EU597251
Mvs/Moscow.RUS/4.07/2 D8 01/07 U Sporadic, unknown source EU597252
Mvs/Moscow.RUS/4.07 D6b 01/07 U No data EU597253
Mvs/Novorossyisk/RUS/4.07/5 D5 01/07 S Sporadic, unknown source NA
Mvs/NizhniyNovgorod.RUS/8.07 D6a 02/07 TS Outbreak, Uzbekistan EU597254
Mvs/Moscow.RUS/15.07/1 D6a 04/07 TS Outbreak, Uzbekistan EU597255
Mvs/Novosibirsk.RUS/16.07 D5 04/07 U Sporadic, unknown source EU597256
Mvs/NizhniyNovgorod.RUS/16.07 D5 04/07 TS Sporadic, Thailand NA
Mvs/Moscow.RUS/16.07/2 D6a 04/07 U No data NA
Mvs/Moscow.RUS/16.07/3 D5 04/07 TS Sporadic, unknown source NA
Mvs/Moscow.RUS/19.07 D6a 05/07 U No data EU925765
Mvs/Ivanovo.RUS/19.07 D6a 05/07 U Sporadic, Uzbekistan NA
Mvs/Krasnoyarsk.RUS/19.07/1 H1 05/07 TS Outbreak, China EU597257
Mvs/Vladivostok.RUS/22.07 H1 05/07 U Outbreak, China EU597258
Mvs/Moscow.RUS/33.07 D8 08/07 TS Sporadic, unknown source EU597264
Strains are listed in order according to date of sample collection.
TS, throat swab; U, urine; PBMC, peripheral blood mononuclear cells; S, serum; NA, not available.
aStrain names and genotypes as recognized by the WHO [19]. The designations D6a and D6b are used in this study to distinguish between two viral lineages of genotype D6.
bDate of sample collection, mm/yy.
cSporadic case or outbreak, indigenous or imported (linked to some country or unknown source), identiﬁed by standard epidemiological methods.
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illumination. PCR products were puriﬁed using Jetquick PCR
Product Puriﬁcation (GENOMED, Lo¨hme, Germany) or Pro-
mega Wizard SV Gel and PCR Clean-up (Promega, Madison,
WI, USA) kits as recommended by the manufacturer.
Sequence analysis
PCR products were sequenced in both directions using the
ABI Prism Big Dye Terminator Cycle Sequencing Kit (Applied
Biosystems, Perkin Elmer-Applied Biosystems, Foster City,
CA, USA) and the corresponding RT-PCR primers (Nf1a and
Nr7a [17,18] or PARMV60 and PARMV63-3 [10]).
Sequences were aligned and analysed using SeqMan II
(DNASTAR Inc., Madison, WI, USA) software and ver-
sion 7.0.9 of BioEdit (Ibis Biosciences, Carlsbad, CA, USA).
Phylogenetic analysis was performed on the basis of the 450
nucleotides coding for the 150 C-terminal amino acids of the
nucleoprotein, as recommended by the WHO [19]. Phyloge-
netic trees were calculated with a neighbour-joining method
(Kimura two-parameter, 1000 bootstraps), using MEGA
version 3.1 [20]. All presented trees are unrooted.
At least one representative of each sequence variant has
been submitted to GenBank, and the corresponding acces-
sion numbers are given in Table 1.
Results
A representative set of MVs (n = 228), collected in different
regions of the Russian Federation between March 2003 and
August 2007, was genotyped by comparing the sequence of
the 450 nucleotides coding for the 150 C-terminal amino acids
of the nucleoprotein with the corresponding sequences of the
current WHO reference strains (data not shown). The strains
were assigned to genotypes D4 (n = 13), D6 (n = 177), H1
(n = 20), D5 (n = 16), and D8 (n = 2), on the basis of their
partial nucleoprotein gene sequences. Table 1 shows a selec-
tion of 74 MV strains that have been used for phylogenetic
analysis. At least one representative strain of each sequence
variant has been included. Several representatives of the same
sequence variant were added if they were obtained in different
regions or imported from other countries into Russia.
Genotype D4 was detected during the ﬁrst 6 months of
2003 in the European part of Russia only. Five sequence vari-
ants with a maximum difference of four nucleotides were
identiﬁed among 13 genotype D4 strains obtained from
outbreaks in Moscow and Astrakhan and a sporadic case in
Saransk (Figs 2 and 6). The corresponding strains had very
similar sequences (zero to four nucleotide differences) to
genotype D4 measles isolates obtained between 1999 and
2001 in the Moscow region [21,22].
The majority of MVs collected between 2003 and 2007
belonged to genotype D6. Genotype D6 was found in very
distant regions, including regions in the western, southern,
central and far eastern parts of the Russian Federation
(Figs 2 and 3). Despite their wide geographical distribution,
the genetic diversity of the corresponding strains was lim-
ited to a maximum difference of four nucleotides (£0.9%).
Most of the genotype D6 sequences were identical or
closely related to one of two major variants. Sequences
that were identical or most similar to the ﬁrst or second
variant are here referred to as lineage D6a or lineage D6b
(Fig. 4). The main variant of lineage D6b had a single nucle-
otide substitution as compared with the main variant of
lineage D6a (T1253G).
The major variant of lineage D6a had a nucleotide
sequence identical to the sequences of viruses that were
detected during the last quarter of 2000 in Germany (MVi/
Berlin.DEU/47.00) or were associated with an outbreak in
Turkey during 2001 [23]. MVs of lineage D6a were detected
in the Russian Federation throughout the period between
2003 and 2007, and accounted for 80/177 (45%) of all geno-
type D6 viruses obtained during this period. Moreover, they
represented 63/70 (90%) of the genotype D6 viruses isolated
between 2003 and 2005.
For the 3 years between 2003 and 2005, most outbreaks
and sporadic cases were due to transmission of the major
variant of lineage D6a. There were several outbreaks in the
North Caucasus in 2003, with 1425 and 996 reported cases
in the Chechen Republic and neighbouring regions, respec-
tively. These outbreaks accounted for 74% of all measles
cases reported from the Russian Federation during 2003.
During the same period, outbreaks were reported from the
Moscow, Kemerovo and Krasnoyarsk regions. Lineage D6a
viruses were obtained from all of these outbreaks, which
comprised up to 90% of the cases reported in 2003.
During 2004 and 2005, the major lineage D6a variant con-
tinued to circulate, and the virus spread to many regions
throughout Russia, causing smaller outbreaks and sporadic
cases. Ten other sequences representing lineage D6a were
obtained in the Republic of Dagestan (one strain), Moscow
(one strain) and the Republic of North Osetia (one strain,
two sequence variants) during 2003, in Rostov-on-Don
(outbreak, seven strains), and Ryazan (one strain) during
2005, in Tver (one strain) and Orenburg (one strain) during
2006, and in Moscow (two strains) during 2007 (Fig. 4).
Most of these sequences differed from the sequence of
the major lineage D6a variant by a single nucleotide substitu-
tion, and the most divergent strain, MVi/Dagestan.RUS/20.03,
had three nucleotide substitutions as compared with the
major variant.
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From the end of 2005, very few cases and outbreaks were
associated with MVs of lineage D6a, and most of them were
linked to importation from Uzbekistan. Thus, in 2006, line-
age D6a viruses were only found in sporadic cases in Tver
and Moscow (two cases, with one imported from Uzbeki-
stan) and two clusters of transmission in Orenburg (both
linked to importation from Uzbekistan).
During the year 2007, an outbreak in Nizhniy Novgorod
(25 cases) was linked to importation of the main variant of
lineage D6a from Uzbekistan. Additionally, a few clusters of
measles cases in Moscow were associated with a new
sequence variant, differing by two nucleotide substitutions
from the latter. The viruses with identical sequences were
associated with an outbreak in Fergana Valley of Uzbekistan
that had been reported some time earlier (Mvs/Andi-
jon.UZB/5.7/1, GenBank).
Lineage D6b viruses were detected for the ﬁrst time from
sporadic measles cases in Vladimir (Mvs/Vladimir.RUS/40.05)
and an outbreak in Kursk during the last quarter of 2005
(Figs 2 and 4) Llineage D6b afterwards became the most
prevalent lineage in the Russian Federation, accounting for
97/177 (55%) of all genotype D6 viruses in 2003–2007, and
90/107 (84%) of genotype D6 viruses obtained since the last
quarter of 2005. At the same time, lineage D6b viruses were
continuously detected during a large outbreak in Ukraine,
with more than 45 000 cases being reported between
December 2005 and October 2006 [24]. The major variant
of lineage D6b and a few other variants of lineage D6b with
single nucleotide differences were obtained from this out-
break [6]. From the end of 2005, most measles cases in the
European part of the Russian Federation were associated
with MVs of lineage D6b, and many of them were epi-
demiologically linked to Ukraine (Fig. 4). Overall, 69/97
viruses were identical to the major variant of lineage D6b.
Additionally, 18 strains were represented by ﬁve sequence
variants differing from the major lineage D6b variant by
single nucleotide substitutions.
Genotypes H1, D5 and D8 were also found in association
with small outbreaks and sporadic cases, but these genotypes
did not spread within the Russian Federation. In 2004, a
D4 D6a H1D6b D5
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FIG. 2. Temporal and geographical dis-
tribution of measles virus genotypes in
the Russian Federation between 2003
and 2006. Each strain is represented
with a distinct symbol, except for Mos-
cow, where numbers of strains of the
different genotypes identiﬁed are shown
in boxes at the top of the map. Regional
designations are (i) Astrakhan; (ii) Sa-
ransk; (iii) Sankt Petersburg; (iv) South
Sakhalinsk; (v) Republic of Dagestan; (vi)
Republic of North Osetia; (vii) Rostov-
on-Don; (viii) Nizhniy Novgorod; (ix)
Ryazan; (x) Tver; (xi) Orenburg; (xii)
Blagoveshchensk; (xiii) Republic of Bury-
atya; (xiv) Vladivostok; (xv) Krasnoyarsk;
(xvi) Chelyabinsk; (xvii) Novosibirsk;
(xviii) Chechen Republic; (xix) Keme-
rovo; (xx) Vladimir; (xxi) Kursk; (xxii)
Novorossiysk; (xxiii) Irkutsk; (xxiv)
Chita; (xxv) Tyumen.
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measles outbreak in Blagoveshchensk (Far Eastern Russia),
involving more than 250 cases, was associated with geno-
type H1. The corresponding strain was identical to viruses
that were isolated earlier in neighbouring China (Fig. 5) [25–
27]. In 2006, genotype H1 was identiﬁed in a sporadic case
from Moscow, which was epidemiologically linked to China. A
small outbreak in the Republic of Buryatya (61 cases) and a
few unrelated sporadic cases in the neighbouring regions were
also associated with genotype H1. In 2007, two small out-
breaks occurred in Vladivostok and Krasnoyarsk after impor-
tation from China. Genotype D5 was identiﬁed during an
outbreak in Chelyabinsk (four cases) in 2006 that was linked
to importation from Thailand. The same genotype was found
during 2007 in some unrelated sporadic cases, one of which
was epidemiologically linked to Thailand (Fig. 5). Furthermore,
genotype D8 was found in two sporadic cases from Moscow
in 2007, but the source of the virus remained unknown.
In 2007, the genetic diversity of MV in the Russian Federa-
tion was signiﬁcantly higher than during previous years. Sev-
eral sequence variants belonging to four different genotypes,
D5 (two variants), D6 (four variants), D8 (two variants), and
H1 (two variants), were identiﬁed, and many cases were
linked to importation or caused by imported viruses
(Table 1).
Discussion
Before 2003, only a small number of Russian MV strains had
been genotyped. Six isolates from local outbreaks in Moscow
(1988) and Siberia (1996) were assigned to genotype A [28].
A single genotype D6 strain was identiﬁed in Novosibirsk in
1997 [28]. In addition, genotype D4 was repeatedly identiﬁed
in the Moscow region between 1998 and 2001 [21,22], but
the overall number of published sequences was low.
The data contributed by this study suggest that geno-
type D4 viruses continuously circulated in Russia between
1999 and early 2003. A progressive accumulation of nucleo-
tide substitutions was observed among genotype D4 strains
detected during this period, although one variant was identi-
ﬁed both in 1999 and 2003 (Fig. 6). Genotype D4 is geneti-
cally diverse, and measles outbreaks associated with this
genotype have been reported from all continents. Geno-
type D4 was endemic during the corresponding period in
eastern and southern Africa, as well as in Central Asia and
the Middle East [11,29]. The Russian MVs belonging to geno-
type D4 were most closely related to viruses identiﬁed in
central Kenya and Ethiopia. As compared with recent geno-
type D4 viruses from Europe, the Russian genotype D4
strains are the most closely related to strains isolated in
Spain in 2002 (sporadic cases of unknown source) [30], and
during an outbreak occurring in Romania between 2004 and
2006.
However, the Russian genotype D4 viruses had at least
three substitutions as compared with the most similar
sequence of MVs from another continent. Therefore, the
repeated detection of similar genotype D4 strains during the
period from 1998 to 2003 probably reﬂects continued circu-
lation of MV in the Moscow region. The relatively high mea-
sles incidence reported between 1998 and 2001 (Fig. 1)
further supports the possibility of continued MV circulation
in the corresponding region.
In 2002, Russia reported a very low measles incidence
(0.4/100 000), with a total of 578 cases. As a result, the
circulation of genotype D4 was probably interrupted in early
2003. Since then, genotype D6 has been identiﬁed in all
D6a H1D6b D5 D8
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FIG. 3. Geographical distribution of
measles virus genotypes and measles inci-
dence in the Russian Federation in 2007.
Each strain is represented by a distinct
symbol, except for Moscow, where num-
bers of strains of the different genotypes
identiﬁed are shown in boxes at the top
of the map. Regional designations are as
described in the legend to Fig. 2.
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regions of the Russian Federation that have reported a high
measles incidence.
The low amount of genetic variability of the genotype D6
strains detected in Russia between 2003 and 2006 suggests
that this genotype has been continuously circulating during
this period. The increased incidence of measles in some
regions of Russia between 2003 and 2006 (Fig. 1) was mainly
associated with the circulation of genotype D6 strains.
As genotype D6 had not been identiﬁed repeatedly in the
Russian Federation before 2003, it was probably imported
from another country.
MVs that have sequences identical to the major variant of
lineage D6a were isolated in Turkey from 2000 to 2001
[23], and in 2004 (GenBank), suggesting a possible source of
importation. Furthermore, MVs of lineage D6a were also
detected in Uzbekistan during 2006 and 2007, and in Kazakh-
stan in 2006 [6]. These countries have experienced a few
large outbreaks since 2002, and as a result of intense migra-
tion, some importation events occurred in the Russian Fed-
eration (Fig. 4, Table 1). The corresponding genotype D6
strains may have been introduced into a group of susceptible
individuals, and may have afterwards spread to other regions
with gaps in the vaccination coverage.
Since the last quarter of 2005, a new lineage of geno-
type D6 (D6b) has replaced the lineage D6a strains. This has
been mainly due to repeated virus importation from a large
outbreak in Ukraine, followed by MV spread within the Rus-
sian Federation. The major lineage D6b variant was ﬁrst
reported from the European part of the Russian Federation,
in association with sporadic cases in Vladimir and an out-
break in Kursk during late 2005 and the beginning of 2006.
The Kursk region shares a border with Ukraine, and no
measles cases had been reported from the regions men-
tioned above during the previous 6 months. In contrast,
more than 2300 measles cases had been reported from
Ukraine during the year 2005, but none of the corresponding
MV strains had been genotyped. Moreover, epidemiologically
conﬁrmed importations of MV from Ukraine to the region of
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FIG. 4. Phylogenetic tree showing viral
lineages of genotype D6 identiﬁed in the
Russian Federation between 2003 and
2007. WHO reference strains are
shown in bold, and designated by their
genotype name. The country of origin is
shown for imported viruses. Weeks of
isolation of identical sequence variants
from the same region are shown in the
boxes. The unrooted phylogenetic tree
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Ryazan in the Russian Federation were reported in June
2005 (unpublished information from the Department of
Epidemiology of the G.N. Gabrichevsky Research Institute,
Moscow). Consequently, many MVs from Ukraine were
genotyped in 2006, indicating the presence of one predomi-
nant variant and of a few others, differing by only a single
nucleotide from the latter [6]. During this period, frequent
transmission of lineage D6b MVs was observed in Russia,
and many cases were associated with MV importation from
Ukraine (Fig. 4, Table 1).
Despite the absence of genotyping data from the early
phase of the Ukrainian outbreak, the ﬁrst lineage D6b-related
cases in the Russian Federation were most probably imported
from Ukraine. Multiple importations of MV from Ukraine
caused outbreaks and sporadic cases in Belarus, Estonia, Latvia,
Bulgaria, Spain, Germany and the UK between 2005 and
2006 [6]. However, in the absence of MV genotype informa-
tion from Ukraine and the other newly independent states
before 2006, the origin of lineage D6b is controversial.
Most of the cases associated with genotypes H1, D5 and
D8 were traced back to virus importations from other coun-
tries. Genotype H1 strains were mainly identiﬁed in the
Asian part of Russia, mostly after importation from China.
The genetic distance among genotype H1 viruses identiﬁed
during different years in different regions of the Russian Fed-
eration reﬂects the high sequence diversity of genotype H1
in China. The high sequence diversity of genotype H1 strains
conﬁrms multiple independent importations, followed by
limited transmission within the Russian Federation in some
cases. Genotype D5 has been continuously detected in
Thailand since 1993 [10], and has also been detected in
association with recent importations from Thailand into the
USA (P.A. Rota, unpublished data). Genotype D8 appears to
be endemic in India [31].
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FIG. 5. Phylogenetic tree of genotype
D5, D8 and H1 strains from Russia and
strains from GenBank. WHO reference
strains are shown in bold, and designated
by their genotype name. Russian strains
are in bold italic. The country of origin is
shown for imported viruses. Tree build-
ing was performed as described in the
legend to Fig. 4.
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Molecular epidemiology thus helped in the investigation of
the circulation of MV in Russia during the past 5 years.
Genotype D4 strains seem to have continuously circulated
between 1998 and 2003. After the incidence of measles had
dropped below 1.0/100 000 in 2002, genotype D4 transmis-
sion was probably interrupted. Thereafter, genotype D6
strains were introduced into some populations with insufﬁ-
cient vaccination coverage, leading to an increased incidence
and continued circulation of the same strains for several
years. The genotype D6-type viruses were persistently circu-
lating in Russia at relatively low levels, and were regularly
imported from neighbouring countries. The steady decrease
in the number of measles cases between 2003 and 2005 was
reversed in 2006, probably because of repeated virus impor-
tation from Ukraine. The low level of genetic diversity within
genotype D6 suggests that there is a limited number of
chains of transmission when there is a high level of popula-
tion immunity.
The present article emphasizes the need for continued
use of molecular techniques to monitor the transmission and
to document the interruption of endemic circulation of MV.
It also underscores the need to maintain high routine vacci-
nation coverage, and it illustrates the contribution of supple-
mentary vaccination campaigns, including broader age groups,
to the elimination of measles.
The co-circulation of multiple imported genotypes,
observed in Russia during 2007, is typical for populations with
low endemic transmission of MV. Measles surveillance helped
to identify gaps in the vaccination coverage that could lead to
a potential resurgence of measles following importation.
Although the succession of prevalent genotypes indicated
suboptimal measles control in the past, the molecular
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FIG. 6. Phylogenetic tree showing mea-
sles virus (MV) strains of genotype D4
identiﬁed in the Russian Federation in
comparison with MV strains from Gen-
Bank. WHO reference strains as estab-
lished by the WHO are shown in bold,
and designated by their genotype name.
Russian strains from 2003 are in bold
italic. Tree building was performed as
described in the legend to Fig. 4.
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epidemiological data, when analysed along with standard case
reporting and classiﬁcation, indicated considerable progress
towards measles elimination in the Russian Federation,
making the goal of eliminating measles by 2010 seem realistic.
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